Brief: Assembly Biosciences Presents New Data At AASLD The Liver Meeting Highlighting Breadth Of Virology Portfolio And Potential Of Next-Generation Core Inhibitors In HBV
04/11/2022 12:05
Nov 4 (Reuters) - Assembly Biosciences Inc ASMB.O :
* ASSEMBLY BIOSCIENCES PRESENTS NEW DATA AT AASLD THE LIVER
MEETING® HIGHLIGHTING BREADTH OF VIROLOGY PORTFOLIO AND
POTENTIAL OF NEXT-GENERATION CORE INHIBITORS IN HBV
Source text for Eikon: ID:nGNX91KDxY
Further company coverage: ASMB.O
((Reuters.Briefs@thomsonreuters.com;;))